Egeen Inc.
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Egeen Inc. - overview
Location
Mountain View, CA, US
Primary Industry
Pharmaceuticals
About
Egeen Inc. is a biotechnology company dedicated to advancing health and wellness through innovative diagnostic tools and therapeutic solutions tailored for medical professionals and patients alike. Egeen Inc. specializes in biotechnology, focusing on the development of diagnostic and therapeutic products.
Founded by Kalev Kask and based in Mountain View, US, the company has had a consistent business strategy without notable pivots. In January 2008, Egeen Inc. raised USD 0. 25 mn in VC funding from Ambient Sound Investments, bringing the total amount raised to USD 0.
25 mn from 3 deals. The company's CEO and founder is Kalev Kask, who has a history of leadership in the sector. Egeen International specializes in the development and provision of advanced biotechnological products focused on enhancing health and wellness. Their core offerings include diagnostic tools and therapeutic solutions targeted at oncology and immunology, designed to improve healthcare professionals' ability to assess and treat patients effectively.
Egeen serves a diverse client base, including healthcare facilities, research institutions, and pharmaceutical companies across North America and Europe, with an emphasis on clinical use and patient empowerment through self-assessment tools. Egeen International generates revenue through direct sales of its proprietary products to healthcare providers and institutions, alongside strategic partnerships with research organizations and pharmaceutical companies. The company's business model is primarily B2B, with clients placing bulk orders for tailored diagnostic and therapeutic solutions. Pricing plans accommodate various operational scales, enabling access for both large healthcare systems and smaller practices, with contracts outlining product specifications and delivery timelines to foster long-term client relationships.
Egeen Inc. plans to utilize the recent funding of USD 0. 25 mn raised in January 2008 to support the development of new diagnostic products set for launch in upcoming quarters. The company aims to expand its market reach into Asia and South America by the end of 2024, tapping into emerging healthcare needs.
This strategic expansion is part of Egeen's commitment to advancing health solutions globally.
Current Investors
Ambient Sound Investments, SEAF, Baltics Small Equity Fund
Primary Industry
Pharmaceuticals
Sub Industries
Pharmaceutical Research & Development
Website
www.egeeninc.com
Company Stage
Series A
Total Amount Raised
Subscriber access only
Egeen Inc. - employee data
Egeen Inc. - key contacts
| Name | Position | Start Date | End Date | Vcard | Bio | ||
|---|---|---|---|---|---|---|---|
| Member Of The Supervisory Board | BM | ||||||
| Founder and board member | BM |
BM Board Member
Want to see more?
Request a demo for full access to this profile
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.